Many people with Parkinson’s disease who take antipsychotic medications begin them shortly after being hospitalized, a new study shows.
Articles by Marisa Wexler, MS
Patterns of brain damage in Parkinson’s disease differ based on whether or not individuals have REM sleep behavior disorder…
A new digital tool called MAP DBS may help improve the efficiency of deep brain stimulation (DBS) for people with…
Several people with Parkinson’s disease were able to improve their ability to walk by using a “wearable cyborg” over their…
A 12-week virtual music therapy program was found to reduce apathy and depression among people with Parkinson’s disease —…
At an upcoming free webinar, hosted by Synapticure, experts will discuss how the chemical trichloroethylene or TCE — a widely-used…
Anxiety is a common problem for people with Parkinson’s disease and can cause substantial difficulties in patients’ day-to-day lives,…
The risk of Parkinson’s disease is increased among people who have been exposed to the chemical trichloroethylene (TCE), according…
BioVie is exploring a potentially pivotal Phase 3 clinical trial to test its experimental oral therapy NE3107 in people with…
Bacteria in the group Desulfovibrio may promote the disease-driving clumping of alpha-synuclein protein in Parkinson’s disease, a new study…